IL2 and cryptococcosis: Studies that sought to explore the pharmacotherapeutics of IFN-gamma also helped shed light on the possible therapeutic benefit of systemic treatment with interleukin 2 (IL-2) and anti-CD20 agents in preventing cerebral cryptococcal infection.